Objective Lumbar discectomy is commonly performed for symptomatic lumbar disc herniation. We aimed to examine prescribing patterns and risk factors for chronic opioid use following lumbar discectomy.
Methods Using a private insurance claims database, patients were identified who underwent primary lumbar discectomy from 2010–2015 and had 1-year of continuous enrollment postoperatively. Patients were excluded with spinal fusion. The strength of opioid prescriptions was quantified using morphine milligram equivalents daily (MMED). Univariate and multivariate logistic regression models were built to examine risk factors associated with chronic postoperative opioid use.
Results A total of 5,315 patients were included in the study (mean age, 59 years; 50% female). 1,198 of patients (23%) used chronic opioids postoperatively. Chronic opioid use declined significantly from 27% in 2010 to 17% in 2015, p < 0.001. In addition, there were significantly fewer patients receiving high and very high-dose opioid prescriptions from 2010–2015, p < 0.001. The median duration that patients used opioids postoperatively was 211 days in 2010 (interquartile range [IQR], 29–356 days), and decreased significantly to 44 days (IQR, 10–294 days) in 2015. The strongest factors associated with chronic opioid use were preoperative opioid use (odds ratio [OR], 4.0), drug abuse (OR, 2.6), depression (OR, 1.6), surgery in the west (OR, 1.6) or south (OR, 1.6), anxiety (OR, 1.5), or 30-day readmission (OR, 1.4).
Conclusion Chronic opioid use following primary lumbar discectomy has declined from 2010–2015. A variety of factors are associated with chronic opioid use. Preoperative recognition of some of these risk factors may aid in perioperative management and counseling.
Citations
Citations to this article as recorded by
Combined pulse radiofrequency and selective nerve root block for lumbar disc herniation-related neuropathic pain: a retrospective cohort study Jie Chen, Hui Lu, Xinchao Jiang, Yi Song, Bin Qian, Mei Fang, Jianxue Qian, Cailin Wang Frontiers in Medicine.2026;[Epub] CrossRef
Opioid Prescribing Trends Following Lumbar Discectomy Albert L. Rancu, Michael J. Gouzoulis, Adam D. Winter, Beatrice M. Katsnelson, Jeremy K. Ansah-Twum, Jonathan N. Grauer Journal of the American Academy of Orthopaedic Surgeons.2025; 33(18): 1054. CrossRef
Trends of opioid use following anterior cervical discectomy and fusion: A 10-year longitudinal study of the Veterans Health Administration Andrew M. Gabig, Paymon G. Rezaii, Sean C. Clark, Bela P. Delvadia, Olivia C. Lee, William F. Sherman, Mathew Cyriac North American Spine Society Journal (NASSJ).2025; 22: 100595. CrossRef
Opioid-use disorder and reported pain after spine surgery: Risk-group patterns in cognitive-appraisal processes in a longitudinal cohort study Carolyn E Schwartz, Katrina Borowiec, Bruce D Rapkin, Joel A Finkelstein, Tai Sutherland, Olivia B Caan, Richard L Skolasky North American Spine Society Journal (NASSJ).2025; 22: 100605. CrossRef
Decreasing utilization of opioids and prescription nonopioids following lumbar discectomy Philip P. Ratnasamy, Gwyneth C. Maloy, John Slevin, Arya G. Varthi, Jonathan N. Grauer North American Spine Society Journal (NASSJ).2025; 24: 100793. CrossRef
The Impact of Preoperative Nicotine Use in the Development of Opioid Use Disorder Following Lumbar Disc Discectomy Procedures: A National Database Study Jinpyo Hong, Andrew Kim, Zachary Freedman, Shoshanna Jadoonanan, David R Hallan, Elias Rizk, John P Kelleher Cureus.2025;[Epub] CrossRef
Association Between Early Surgery and Postoperative Opioid Use in Patients With Lumbar Disc Herniation: A Propensity Score-Matching Analysis Using an Administrative Claims Database in Japan Akira Honda, Yoichi Iizuka, Mieda Tokue, Eiji Takasawa, Sho Ishiwata, Yusuke Tomomatsu, Shunsuke Ito, Kazuhiro Inomata, Akira Okada, Hiroki Matsui, Hideo Yasunaga, Hirotaka Chikuda Global Spine Journal.2024; 14(6): 1738. CrossRef
A study on the 10-year trend of surgeries performed for lumbar disc herniation and comparative analysis of prescribed opioid analgesics and hospitalization duration: 2010–2019 HIRA NPS Data Sang Yoon Kim, Yu-Cheol Lim, Byung-Kwan Seo, Dongwoo Nam, In-Hyuk Ha, Ye-Seul Lee, Yoon Jae Lee BMC Musculoskeletal Disorders.2024;[Epub] CrossRef
Biportal Endoscopic Spine Surgery for Lumbar Laminectomy and Diskectomy: Postoperative Outcomes and Surgical Learning Curve, a Single US Surgeon's Experience Matthew Easthardt, Philip Zakko, Ali Jawad, Maximillian Lee, Daniel Park JAAOS: Global Research and Reviews.2024;[Epub] CrossRef
The Current Status of Awake Endoscopic Surgery: A Systematic Review and Meta-Analysis Caroline N. Jadczak, Nisheka N. Vanjani, Hanna. Pawlowski, Elliot D.K. Cha, Conor P. Lynch, Michael C. Prabhu, Timothy J. Hartman, James W. Nie, Keith R. MacGregor, Eileen. Zheng, Omolabake O. Oyetayo, Kern. Singh World Neurosurgery.2023; 180: e198. CrossRef
Endogenous opiates and behavior: 2020 Richard J. Bodnar Peptides.2022; 151: 170752. CrossRef
Objective The aim of the study was to compare trends and differences in preoperative and prolonged postoperative opioid use following spinal cord stimulator (SCS) implantation and to determine factors associated with prolonged postoperative opioid use.
Methods A database of private-payer insurance records was queried to identify patients who underwent a primary paddle lead SCS placement via a laminectomy (CPT-C3655) from 2008–2015. Our resulting cohort was stratified into those with prolonged postoperative opioid use, opioid use between 3- and 6-month postoperation, and those without. Multivariate logistic regression was used to determine the effect preoperative opioid use and other factors of interest had on prolonged postoperative opioid use. Subgroup analysis was performed on preoperative opioid users to further quantify the effect of differing magnitudes of preoperative opioid use.
Results A total of 2,374 patients who underwent SCS placement were identified. Of all patients, 1,890 patients (79.6%) were identified as having prolonged narcotic use. Annual rates of preoperative (p = 0.023) and prolonged postoperative narcotic use (p < 0.001) decreased over the study period. Significant independent predictors of prolonged postoperative opioid use were age < 65 years (odds ratio [OR], 1.52; p = 0.004), male sex (OR, 1.33; p = 0.037), preoperative anxiolytic (OR, 1.55; p = 0.004) and muscle relaxant (OR, 1.42; p = 0.033), and narcotic use (OR, 15.04; p < 0.001). Increased number of preoperative narcotic prescriptions correlated with increased odds of prolonged postoperative use.
Conclusion Patients with greater number of preoperative opioid prescriptions may not attain the same benefit from SCSs as patients with less opioid use. The most significant predictor of prolonged narcotic use was preoperative opioid use.
Citations
Citations to this article as recorded by
Change in opioid use following spinal cord stimulation: a systematic review and meta-analysis Hunter Soleymani, Mahmoud Morsi, Kira Kopacz, Jay Karri, Lisa Goudman, Nasir Hussain, Saba Javed, Ryan D’Souza Regional Anesthesia & Pain Medicine.2026; : rapm-2026-107603. CrossRef
The impact of opioid prescribing guidelines on opioid dispensation: A systematic review and meta-analysis Jihoon Lim, Parker Tope, Maximilian Schaefer, Isaiah Williams, Imen Farhat, Andrea Benedetti, Dimitra Panagiotoglou Canadian Journal of Pain.2026;[Epub] CrossRef
US Department of Defense consensus guidelines on neuromodulation for pain management in an active-duty military population from a tri-service, multispecialty working group Brian C McLean, Christopher R Phillips, Sara M Wilson, Jason D Merrell, Harold Gelfand, David E Reece, David Riegleman, Stephen E Rodriguez, Steven Paul Cohen Regional Anesthesia & Pain Medicine.2026; : rapm-2026-107787. CrossRef
Curcumin reduces pain after spinal cord injury in rats by decreasing oxidative stress and increasing GABAA receptor and GAD65 levels Maryam Hadadi, Mohammad Mojtaba Farazi, Mehrnaz Mehrabani, Mahsa Tashakori-Miyanroudi, Zahra Behroozi Scientific Reports.2025;[Epub] CrossRef
The impact of perioperative opioid use on postoperative outcomes following spinal surgery: a meta-analysis of 60 cohort studies with 13 million participants Mingjiang Luo, Fuwen Shi, Hongxu Wang, Zuoxuan Chen, Huijie Dai, Yuxin Shi, Jiang Chen, Siliang Tang, Jingshan Huang, Zhihong Xiao The Spine Journal.2024; 24(2): 278. CrossRef
Functional Somatic Syndromes Are Associated With Varied Postoperative Outcomes and Increased Opioid Use After Spine Surgery: A Systematic Review Raisa Masood, Taryn E. LeRoy, Michael A. Moverman, Matthew W. Feldman, Ashley Rogerson, Matthew J. Salzler Global Spine Journal.2024; 14(5): 1601. CrossRef
Cross-Country Differences in Pain Medication Before and After Spinal Cord Stimulation: A Pooled Analysis of Individual Patient Data From Two Prospective Studies in the United Kingdom and Belgium Lisa Goudman, Rui V. Duarte, Ann De Smedt, Sue Copley, Sam Eldabe, Maarten Moens Neuromodulation: Technology at the Neural Interface.2023; 26(1): 215. CrossRef
Optimizing Preoperative Chronic Pain Management in Elective Spine Surgery Patients Emily Arciero, Josephine R. Coury, Alexandra Dionne, Justin Reyes, Joseph M. Lombardi, Zeeshan M. Sardar JBJS Reviews.2023;[Epub] CrossRef
Detoxification of Neuromodulation-Eligible Patients by a Standardized Protocol: A Retrospective Pilot Study Ali Jerjir, Lisa Goudman, Jean-Pierre Van Buyten, Ann De Smedt, Iris Smet, Marieke Devos, Maarten Moens Neuromodulation: Technology at the Neural Interface.2022; 25(1): 114. CrossRef
Baseline Risk Factors for Prolonged Opioid Use Following Spine Surgery: Systematic Review and Meta-Analysis Shruthi Mohan, Conor P. Lynch, Elliot D.K. Cha, Kevin C. Jacob, Madhav R. Patel, Cara E. Geoghegan, Michael C. Prabhu, Nisheka N. Vanjani, Hanna Pawlowski, Kern Singh World Neurosurgery.2022; 159: 179. CrossRef
Endogenous opiates and behavior: 2020 Richard J. Bodnar Peptides.2022; 151: 170752. CrossRef
Association of Spinal Cord Stimulator Implantation With Persistent Opioid Use in Patients With Postlaminectomy Syndrome To-Nhu Vu, Chachrit Khunsriraksakul, Yakov Vorobeychik, Alison Liu, Renan Sauteraud, Ganesh Shenoy, Dajiang J. Liu, Steven P. Cohen JAMA Network Open.2022; 5(1): e2145876. CrossRef
The Role of Spinal Cord Stimulation in Reducing Opioid Use in the Setting of Chronic Neuropathic Pain Cynthia A. Smith, Jessica Roman, Antonios Mammis The Clinical Journal of Pain.2022; 38(4): 285. CrossRef
Comparison of Spinal Cord Stimulation Outcomes Between Preoperative Opioid Users and Nonusers: A Cohort Study of 467 Patients Dennis Møgeltoft Poulsen, Lone Nikolajsen, Morten Rune Blichfeldt-Eckhardt, Helga Angela Gulisano, Jens Christian Hedemann Sørensen, Kaare Meier Neuromodulation: Technology at the Neural Interface.2022; 25(5): 700. CrossRef
Efecto de las características del paciente en los resultados clínicos más de 12 meses después de la implantación de la estimulación del ganglio de la raíz dorsal: una revisión retrospectiva Jonathan M. Hagedorn, Ian McArdle, Ryan S. D’Souza, Abhishek Yadav, Alyson M. Engle, Timothy R. Deer NeuroTarget.2022; 16(1): 54. CrossRef
Use of Pulsed Radiofrequency for the Treatment of Discogenic Back Pain: A Narrative Review Seoyon Yang, Mathieu Boudier‐Revéret, Min Cheol Chang Pain Practice.2021; 21(5): 594. CrossRef
Opioid use and spinal cord stimulation therapy: The long game Brian Y. Hwang, Serban Negoita, Phan Q. Duy, Yohannes Tesay, William S. Anderson Journal of Clinical Neuroscience.2021; 84: 50. CrossRef
Effect of Patient Characteristics on Clinical Outcomes More Than 12 Months Following Dorsal Root Ganglion Stimulation Implantation: A Retrospective Review Jonathan M. Hagedorn, Ian McArdle, Ryan S. D’Souza, Abhishek Yadav, Alyson M. Engle, Timothy R. Deer Neuromodulation: Technology at the Neural Interface.2021; 24(4): 695. CrossRef
Opioid use following a total shoulder arthroplasty: who requires refills and for how long? Corey C. Spencer, Jeremiah A. Pflederer, Jacob M. Wilson, Alexander M. Dawes, Michael B. Gottschalk, Eric R. Wagner JSES International.2021; 5(3): 346. CrossRef
A Call to Action Toward Optimizing the Electrical Dose Received by Neural Targets in Spinal Cord Stimulation Therapy for Neuropathic Pain Krishnan Chakravarthy, Rajiv Reddy, Adnan Al-Kaisy, Thomas Yearwood, Jay Grider Journal of Pain Research.2021; Volume 14: 2767. CrossRef
Spinal cord stimulation and psychotropic medication use: Missing piece to the puzzle? Brian Y. Hwang, Serban Negoita, Phan Q. Duy, William S. Anderson Journal of Clinical Neuroscience.2020; 81: 158. CrossRef
Objective Although spinal cord stimulators (SCS) continue to gain acceptance as a viable nonpharmacologic option for the treatment of chronic back pain, recent trends are not well established. The aim of this study was to evaluate recent overall demographic and regional trends in paddle lead SCS placement and to determine if differences in trends exist between private-payer and Medicare beneficiaries.
Methods A retrospective review of Medicare and private-payer insurance records from 2007–2014 was performed to identify patients who underwent a primary paddle lead SCS placement via a laminectomy (CPT-63655). Each study cohort was queried to determine the annual rate of SCS placements and demographic characteristics. Yearly SCS implantation rates within the study cohorts were adjusted per 100,000 beneficiaries. A chi-square analysis was used to compare changes in annual rates.
Results A total of 31,352 Medicare and 2,935 private-payer patients were identified from 2007 to 2014. Paddle lead SCS placements ranged from 5.9 to 17.5 (p<0.001), 1.9 to 5.9 (p<0.001), and 5.2 to 14.5 (p<0.001) placements per 100,000 Medicare, private-payer, and overall beneficiaries respectively from 2007 to 2014. SCS placements peaked in 2013 with 19.6, 7.1, and 16.8 placements per 100,000 Medicare, private-payer, and overall patients.
Conclusion There was an overall increase in the annual rate of SCS placements from 2007 to 2014. Paddle lead SCS placements peaked in 2013 for Medicare, private-payer, and overall beneficiaries. The highest incidence of implantation was in the Southern region of the United States and among females. Yearly adjusted rates of SCSs were higher among Medicare patients at all time points.
Citations
Citations to this article as recorded by
Military concerns for chronic pain stimulator devices Scott Hughey, R Field, D Campbell, J Cole, G Booth, M Stringer, E Stedjelarsen BMJ Military Health.2025; 171(1): 70. CrossRef
The Impact of Racial and Low Socioeconomic Status on the Implementation of Spinal Cord Stimulation for Chronic Pain in the United States Gabriel Howard, Luis Guinand, Eric Xu, Alex Kervyn, Behnum Habibi Current Pain and Headache Reports.2025;[Epub] CrossRef
Socioeconomic Determinants of Initiating Neuromodulation for Chronic Pain: A Systematic Review Maarten Moens, Julie G. Pilitsis, Lawrence Poree, Yadeline Azurin, Maxime Billot, Manuel Roulaud, Philippe Rigoard, Lisa Goudman Neuromodulation: Technology at the Neural Interface.2024; 27(8): 1266. CrossRef
Development of a Modified Bayonet Forceps for Improving Steerability of Paddle Lead Electrodes During Spinal Cord Stimulator Surgery: A Technical Note Justin K. Zhang, Alborz Alimadadi, Mohammad Abolfotoh, Philippe Mercier, Tobias A. Mattei Operative Neurosurgery.2023; 25(3): 285. CrossRef
Health Care Disparity in Pain Travis M. Hamilton, Jared C. Reese, Ellen L. Air Neurosurgery Clinics of North America.2022; 33(3): 251. CrossRef
Recent Trends in Medicare Utilization and Reimbursement for Spinal Cord Stimulators: 2000–2019 Marcus Romaniuk, Giyth Mahdi, Rohin Singh, Jack Haglin, Nolan J. Brown, Oren Gottfried World Neurosurgery.2022; 166: e664. CrossRef
Erector Spinae Plane Catheter for Postoperative Thoracotomy Pain in a Patient With Indwelling Spinal Cord Stimulators: A Case Report David T Cheng, Eldhose Abrahams, Aimee Pak Cureus.2022;[Epub] CrossRef
First
Prev
